Bioventix (LON:BVXP) Insider Ian James Nicholson Purchases 1,000 Shares

Bioventix PLC (LON:BVXP) insider Ian James Nicholson acquired 1,000 shares of the firm’s stock in a transaction dated Friday, April 10th. The shares were purchased at an average price of GBX 1,848 per share, with a total value of £18,480.

Bioventix Stock Up 0.5%

BVXP opened at GBX 1,900 on Tuesday. Bioventix PLC has a twelve month low of GBX 1,300 and a twelve month high of GBX 3,020. The company has a fifty day moving average of GBX 1,603.59 and a 200-day moving average of GBX 1,872.17. The stock has a market cap of £99.28 million, a PE ratio of 13.52 and a beta of 0.48.

Bioventix (LON:BVXP) last posted its quarterly earnings data on Monday, March 30th. The biotechnology company reported GBX 69.38 earnings per share for the quarter. Bioventix had a net margin of 59.30% and a return on equity of 65.83%. The company had revenue of GBX 615.88 billion during the quarter. Sell-side analysts anticipate that Bioventix PLC will post 166.3066955 EPS for the current fiscal year.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.